ozempic lawsuit Updates
Ozempic Launches in Indian Market Amid Growing Global Litigation Over Side Effects
Novo Nordisk has launched its diabetes and weight-loss drug Ozempic in India, pricing a 0.25 mg pen at approximately $24.35. The introduction targets India's large type-2 diabetes population and growing obesity concerns. This global expansion occurs alongside increasing litigation in the United States, where a consolidated multidistrict lawsuit alleges Novo Nordisk failed to warn patients about severe potential side effects, including gastroparesis and pancreatitis. The litigation continues to grow as use of GLP-1 receptor agonists like Ozempic rises worldwide.
Ozempic Face" Emerges as Aesthetic Concern Amid Ongoing Product Liability Litigation
Medical professionals are noting an aesthetic condition colloquially termed "Ozempic Face," characterized by facial skin sagging and a hollowed appearance following rapid weight loss from GLP-1 drugs like Ozempic. This occurs when skin lacks time to contract naturally after fat and muscle reduction. Separately, consolidated multidistrict litigation against manufacturer Novo Nordisk continues to advance. These lawsuits allege the company failed to adequately warn patients and physicians about risks of more severe side effects, including gastroparesis, ileus, pancreatitis, and a type of blindness known as NAION.
Ozempic, GLP-1 Drug Litigation MDL Nears 3,000 Cases with Continued Growth
The multidistrict litigation (MDL) concerning Ozempic and similar GLP-1 receptor agonist drugs continues to expand significantly, reflecting their widespread use. In November 2025 alone, 27 new cases were added, bringing the total number of consolidated lawsuits to 2,947. This steady upward trend is driven by allegations from patients who claim the manufacturers failed to adequately disclose or warn about the risks of certain severe side effects associated with these medications.
Tepezza Hearing Loss MDL Grows to 273 Cases Amid Steady Filings
The multidistrict litigation (MDL 3090) concerning hearing loss and related injuries allegedly caused by the thyroid eye disease drug Tepezza continues its steady growth. In November 2025, one new case was added, bringing the total number of pending lawsuits to 273. While the current pace of monthly filings remains modest, the consistent accumulation of claims suggests that further cases are likely as patient and physician awareness of the alleged risks continues to increase. The litigation remains active before Chief Judge Rebecca R. Pallmeyer in the Northern District of Illinois.
About the Ozempic Lawsuit
The Ozempic lawsuit has recently gained significant attention as concerns have been raised about Ozempic long term side effects, including gastroparesis, thyroid C-cell tumors, and other serious illnesses.
The core issue of the Ozempic class action lawsuit is the potential serious health risks associated with the use of Ozempic, a medication commonly prescribed to manage type 2 diabetes by controlling blood sugar levels. These issues have led to numerous reports and studies focusing on the potential dangers of the active ingredient in Ozempic, semaglutide.
People afflicted with Ozempic's long-term side effects include individuals who have been prescribed the medication for diabetes management and subsequently experienced serious health issues. Individuals who used Ozempic for weight loss were unaware of the potential risks associated with the medication.
Victims who used Ozempic for weight loss are facing significant health challenges, permanent disabilities, and, in some cases, life-threatening conditions. Many people are unaware of the risks and continue using the medication, only to experience severe health issues. Legal avenues are now available for those affected, allowing them to submit an application and seek potential compensation for the harm caused by Ozempic.
If you or a loved one have suffered serious health issues after using Ozempic, it is crucial to understand your rights and the potential for participating in the Ozempic lawsuit to seek justice and compensation.
Who Qualifies for the Ozempic Lawsuit?
There are specific criteria you must meet to potentially qualify for the Ozempic lawsuit. These requirements include.
Medication Use: You must have been prescribed and used Ozempic between 2018 and to present.
Health Conditions: You must have been diagnosed with one of the following Ozempic side effects:
- Persistent cyclical vomiting for +4 weeks (diagnosis must be while taking the product OR within 60 days of stopping and must have experienced vomiting 1 month or more)
- Gastric Injury (diagnosis must be while taking product OR within 60 days of stopping)
- A gastric injury is any injury related to the gastrointestinal tract
- Ileus
- Gastroparesis/ stomach paralysis
- Pulmonary Aspiration (associated with anesthesia/surgery)
- Deep Vein Thrombosis (DVT)
- Esophageal Injury
Vision Risks: You must have been diagnosed with NAION (Non-arteritic Anterior Ischemic Optic Neuropathy) by a medical professional following the use of Ozempic or another semaglutide-based medication.
Users of Ozempic or similar GLP-1 drugs may experience rare but serious vision-related side effects. One reported condition is Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), a sudden and painless loss of vision in one eye, often referred to as an “eye stroke.”
NAION occurs when blood flow to the front of the optic nerve is reduced, leading to nerve damage, swelling, and partial or permanent vision loss. This condition is estimated to affect approximately 1 in 10,000 users and is more commonly seen in individuals over the age of 50, particularly those with underlying risk factors such as high blood pressure, diabetes, or sleep apnea.
If you do not have a valid cancer diagnosis from your doctor but have experienced Ozempic side effects, you may still be included in the Ozempic lawsuit.
If you meet these requirements, you may be entitled to compensation and should seek legal advice to determine your eligibility.
Which Companies Are Involved in the Ozempic Lawsuit?
Several manufacturers and their respective products are commonly implicated in the Ozempic lawsuit, however, the primary company involved is Novo Nordisk. Novo Nordisk is facing numerous lawsuits alleging that the science behind Ozempic was wrong and that it has led to serious health conditions, including gastroparesis, ileus, and other significant health issues.
These Ozempic lawsuits claim that Novo Nordisk failed to adequately warn users about the potential risks associated with the drug's active ingredient, semaglutide. As more evidence emerges linking to Ozempic's long-term side effects, the number of cases against the company is expected to increase. If you or a loved one have experienced adverse health effects after using Ozempic, you may qualify to join the ongoing litigation.
How Much Compensation Should You Expect In Your Ozempic Lawsuit?
Determining a typical settlement amount in the Ozempic lawsuit is complex due to the unique nature of each case. Factors such as the severity of the illness, the strength of the evidence, jury decisions, and the skill of the lawyers involved all influence the settlement amount.
As of now, the Ozempic lawsuits are in the early stages, and no global settlements or jury trials have been reported. However, based on other pharmaceutical litigation and the current scope of the Ozempic cases, potential settlement amounts can be anticipated based on the type and extent of harm suffered by plaintiffs.
Add Comment